Covid 19 death analysis in Colombia

Palabras clave: SARS-CoV-2, COVID-19, Colombia


Introduction: This article shows an analysis of the evolution up until date (May 4-2021), of official coronavirus cases statistics (CC) and the total number of deaths (TND) due to SARS-CoV-2 in Colombia. Additionally, said information is shown in correlation to other variables such as Case Fatality Rate (CFR), age range of persons, their typical reported co-morbidities and the cities where there has been highest concentration of cases. Materials and Methods: From March 16 2020 until today, information regarding the daily number of new confirmed cases (DNC) and daily confirmed deaths (DD) was registered in a database with the purpose of estimating the evolution of CC, TND and CFR. The age of deceased was also registered, as well as their gender, prior co-morbidities and city of death. The evolution of TND with the time of other countries were compared to that of Colombia. A mathematical equation that represents the epidemiological curve of TND evolution of different countries across time was defined. Results: In Colombia, the average age of people who die due to COVID-19 is of 69.5±14.7 years (median and mode of 71 and 80 years, respectively), and the virus is less lethal amongst a population under the age of 40. The greater part of deaths have taken place in people with prior co-morbidities and of the male gender. Conclusion: Most of the persons that have deceased are those of senior age, mainly with prior co-morbidities, and predominantly of male gender. Epidemiological peaks of COVID-19 are consistent with the rainy and winter seasons, and with the traditional epidemiological peaks of flu or influenza.

How to cite this Article: Rondón-Quintana Hugo Alexander, Zafra-Mejía Carlos Alfonso. Covid 19 death analysis in Colombia. Revista Cuidarte. 2021;12(3):e.1528


La descarga de datos todavía no está disponible.

Biografía del autor/a

Hugo Alexander Rondón-Quintana, Universidad Distrital Francisco José de Caldas

Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.

Carlos Alfonso Zafra-Mejía, Universidad Distrital Francisco José de Caldas

Universidad Distrital Francisco José de Caldas, Bogotá D.C., Colombia.


Gorbalenya AE, Baker SC, Baric RS, Groot RJ, Drosten C, Gulyaeva, AA, Haagmans BL. et al. Severe acute respiratory syndrome-related coronavirus—the species and its viruses, a statement of the coronavirus study group. Nat Microbiol. 2020;5:536–44.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) Outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239-42.

Liu Y, Gayle AA, Wilder-Smith A, Rocklov J. The reproductive number of covid-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2):1–4.

Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020;25(5): 2000062.

Yang Y, Liu MJ, Wang YX, Zhang AR, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. MedRxiv. 2020.

Xie M, Chen Q. Insight into 2019 novel coronavirus — an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020;94:119–24.

Alshogran O Y, Altawalbeh, S M, Al-Azzam, S I, Karasneh, R. Predictors of Covid-19 case fatality rate: An ecological study. Ann Med. Surgery, 2021;65:102319.

Mazza M G, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni E M T, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600.

Khan S, Siddique R, Bai Q, Shabana Y, Xue M, Nabi G, Liu, J. Coronaviruses disease 2019 (COVID-19): Causative agent, mental health concerns, and potential management options. J Infect Public Heal. 2020.

Khan I, Haleem A, Javaid M. Analysing COVID-19 pandemic through cases, deaths, and recoveries. J Oral Biol Craniofac Res. 2020;10(4):450-69.

Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, Abosalif K, Ahmed Z, Younas E. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Heal, Available online 4 August 2020:In Press, Corrected Proof.

Mandal CC, Panwar, MS. Can the summer temperatures reduce COVID-19 cases? Public Health, 2020;185:72-9.

Haque SE, Rahman M. Association between temperature, humidity, and COVID-19 outbreaks in Bangladesh. Environ Sci Policy, 2020;114:253-255.

Sartor G, Del Riccio M, Dal Poz I, Bonanni P, Bonaccorsi G. COVID-19 in Italy: Considerations on official data. Int J Infect Dis. 2020;98:188-190.

Departamento Administrativo Nacional de Estadística (DANE). Información Capital. 2019 [Consulted on 1 of May of 2021].

Ministerio de Salud (MINSALUD). Lineamientos para la prevención, diagnóstico, manejo y control de casos de Influenza. 2018 [Consulted on 1 of May of 2021].

Chowell G, Sattenspiel L, Bansal S, Viboud C. Mathematical models to characterize early epidemic growth: a review. Phys Life Rev. 2016;18:66–97.

De la Hoz-Restrepo F, Alvis-Zakzuk NJ, De la Hoz-Gomez JF, De la Hoz-Gomez A, Gomez Del Corral L, Alvis-Guzmán N. Is Colombia an example of successful containment of the COVID-19 2020 pandemic? A critical analysis of the epidemiological data. March to July 2020. Int J Infect Dis. 2020;99:522-9.

Departamento Administrativo Nacional de Estadística (DANE). Pobreza y desigualdad. 2020 [Consulted on 24 of May of 2020].

Ministerio de Salud. Desnutrición infantil en Colombia: Marco de referencia. Papeles en Salud Edición No. 03 agosto de 2016 Bogotá D.C. [Consulted on 5 of July of 2020].

Departamento Administrativo Nacional de Estadística (DANE). Defunciones no fetales. 2019 [Consulted on 5 of July of 2020]. defunciones/defunciones-no-fetales/defunciones-no-fetales-2019

Departamento Administrativo Nacional de Estadística (DANE). Gran encuesta integrada de hogares (GEIH) Mercado laboral. 2020 [Consulted on 5 of July of 2020].

Departamento Administrativo Nacional de Estadística (DANE). Censo Nacional de Población y Vivienda 2018. 2018 [Consulted on 30 of April of 2020].

Badawi A, Ryoo SG. Prevalence of comorbidities in the middle east respiratory syndrome coronavirus (MERS-Cov): A systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–33.

Lai C, Shih T, Ko W, Tang H, Hsueh P. Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.

Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allerg Immu. 2019;56(3):308–21.

Bonmarin I, Belchior E, Bergounioux J, Brun-Buisson C, Megarbane B, Chappert J L, et al. Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons. Euro Surveill. 2015;20(46).

Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, et al. Severe influenza in 33 US hospitals, 2013-2014: complications and risk factors for death in 507 patients. Infec Control Hosp Epidemiol. 2015;36(11):1251-60.

Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347: f5061.

Goeijenbier M, van Sloten T T, Slobbe L, Mathieuf C, van Genderen P, Beyer W, Osterhaus A. Benefits of flu vaccination for persons with diabetes mellitus: a review. Vaccine 2017;35(38):5095–101.

Zhang ZXZ, Kyaw W, Ho HJ, Tay MZ, et al. Seasonal influenza-associated intensive care unit admission and death in tropical Singapore 2011-2015. J Clin Virol. 2019;117:73-9.

Zou Q, Zheng S, Wang X, Liu S, Bao J, et al. Influenza a-associated severe pneumonia in hospitalized patients: risk factors and NAI treatments. Int J Infect Dis. 2020;92:208-13.

Guerrero N, Yépez-Ch M C. Factores asociados a la vulnerabilidad del adulto mayor con alteraciones de salud [Factors associated with the vulnerability of the elderly with health disorders] Universidad y Salud, 2015;17(1):121-31.

Al-Qahtani A. Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2): Emergence, history, basic and clinical aspects. Saudi J Biol Sci. 2020;27(10):2531-8.

Guan W, Ni Z, Yu H, Liang H, Ou C, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England J Med. 2020;382:1708-20.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020;395:507–13.

Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Diseases, 2020;29(8):104949.

Sanchez-Ramirez DC, Mackey, D. Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis. Respir Med. 2020;171:106096.

Yadav R, Aggarwal S, Singh A. SARS-CoV-2-host dynamics: Increased risk of adverse outcomes of COVID-19 in obesity. Diabetes Metab Syndr: Clinical Research & Reviews, 2020;14(5):1355-60.

Cómo citar
Rondón-Quintana HA, Zafra-Mejía CA. Covid 19 death analysis in Colombia. Rev Cuid [Internet]. 20 de agosto de 2021 [citado 28 de septiembre de 2021];12(3). Disponible en:
Artículos de Investigación